HIMS & HERS HEALTH, INC. vs Privia Health Group, Inc., two Medical Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where HIMS and PRVA diverge most: on operating margin, HIMS reads -12.9% and PRVA reads 1.2%; on net margin, HIMS reads -0.6% and PRVA reads 1.0%. The rest of the comparable metrics sit closer together. What PRVA's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | HIMS | PRVA |
|---|---|---|
| Price | $27.77 | $23.65 |
| Market cap | $6.3B | $3.0B |
| Sector | Medical Services | Medical Services |
| Stage | Growth | Growth |
| P/B | 14.21 | 3.70 |
| P/S | 2.68 | 1.33 |
| EV/EBITDA | 111.5 | 53.6 |
| Revenue growth | +38.5% | +24.8% |
| Gross margin | 65.3% | — |
| Operating margin | -12.9% | 1.2% |
| Net margin | -0.6% | 1.0% |
| Return on equity | -3.0% | 2.7% |
| Return on assets | -0.6% | 1.5% |
| Return on invested capital | 2.3% | 3.6% |
| FCF yield | 0.9% | 4.6% |
| Debt / equity | 2.18 | 0.00 |
| Current ratio | 1.69 | 1.61 |
| Altman Z (solvency) | 3.12 | 4.68 |
| Piotroski F (quality) | 4 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.